FindTrial
Sign In

Designing a Questionnaire to Detect High-Risk Cases of Metabolic Cardiomyopathy in the Context of Myocardial Hypertrophy

Designing a Questionnaire to Detect High-Risk Cases of Metabolic Cardiomyopathy in the Context of Myocardial Hypertrophy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112162
Enrollment
Unknown
Registered
2025-11-11
Start date
2025-10-14
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Cardiomyopathy (HCM),Transthyretin Amyloid Cardiomyopathy (ATTR-CM), Fabry Disease

Interventions

Gold Standard:a-Gal A activity + GLA gene + Lyso-GL-3 for FD
99mTc-PYP scintigraphy + TTR gene for ATTR-CM
Index test:Questionnaire for Screening High-Risk Populations of Metabolic Cardiomyopathy in Patients with Myocardial Hypertrophy

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Transthoracic echocardiography indicates myocardial hypertrophy or thickening; 2.Capable of understanding and signing the informed consent form.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Comprehensive parameters;Sensitivity;Specificity;—

Countries

China

Contacts

Public ContactRong Jiang

Shanghai General Hospital

listening39@163.com+86 21 63240090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026